| Price and Chart delayed at least 15 mintues. |
|
Price
$ 51.47
|
Change
0.00
|
|
Open
0.00
|
% Change
0.0%
|
|
Prev Close
51.47
|
Volume
NA
|
|
Market Value
52 bil
|
P/E Ratio
13.4
|
|
Bid
50.90
|
EPS
3.85
|
|
Ask
53.80
|
Dividend
0.00
|
|
High
0.00
|
Yield
0.0
|
|
Low
0.00
|
Shares Out
1.01 bil
|
|
52wk High
66.51
|
52wk Low
44.96
|
|
Industry: Biotechnology
|
|
Sector: Healthcare
|
AMGN Profile
A global biotechnology company which discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology.
Amgen, Inc.
One Amgen Center Drive
Thousand Oaks, CA 91320-1799
Phone: (805) 447-1000
Fax: (805) 447-1010
Web Site: www.amgen.com
AMGN Wires Headlines
|
|
| 07.04.09 |
|
More power for shareholders in ND pension funds?
|
|
| 07.02.09 |
|
Final Glance: Biotechnology companies
|
|
| 07.02.09 |
|
Midday Glance: Biotechnology companies
|
|
| 07.02.09 |
|
Early Glance: Biotechnology companies
|
|
| 07.01.09 |
|
Final Glance: Biotechnology companies
|
More AMGN From Wires Headlines >
Forbes.com on AMGN RSS
|
|
|
Amgen is ranked # 180 on the 2009 Forbes 2000 List
|
|
Thomson / IBES Earnings Estimates on AMGN
Accounting Risk
Buy/Hold/Sell Analysis
Forbes Investment Guru Commentary on AMGN
RSS News Feed on AMGN
|
A D V E R T I S E M E N T
|